IMS Health has completed the acquisition of a provider of clinical trial cost benchmarks, budgeting and negotiation tools, TTC. The acquisition will enable IMS Health's clients to enhance the speed, efficiency and cost-effectiveness ...
Tags: Acquisition, clinical industry, IMS health
The European Commission (EC) has granted a €6m grant to the "FIGHT HLH" consortium of institutions to support clinical testing of NovImmune's anti-interferon gamma drug candidate, NI-0501. The FIGHT HLH consortium lead by NovImmune ...
TKL Research has selected Medidata CTMS clinical trial management system to expand its clinical trial operations. The software-as-a-service allows TKL to identify sites that can enroll the exact patients by measuring actual ...
Tags: clinical trial management system, pharmaceuticals industry
Merck has issued an update on the development programs for vorapaxar, extended release niacin/laropirprant(MK524A,Tredaptive) and anacetrapib in association with the European Society of Cardiology (ESC) meeting in Munich, Bavaria. ...
Tags: Merck, vorapaxar, HPS2-THRIVE
Paperboard packaging manufacturer in the US Keystone Folding Box Company has announced the launch of its new prescription pharmaceutical package Ecoslide-RX at Walmart stores. According to the company, the package has an eco-friendly ...
Pharmaceutical and diagnostic company Prometheus Laboratories has granted an oncology programme to Clinipace Worldwide, a global digital research organization (dCRO). As part of the contract, Clinipace Worldwide will study Proleukin ...
Tags: medical research, data management platform, clinical trial
Kaketsuken, also known as the Chemo-Sero-Therapeutic Research Institute, has become the first Japanese pharmaceutical company to use the combined capabilities of the Medidata Balance and Medidata Rave for a Japanese clinical trial. ...
US Department of Defense has granted a Congressionally Directed Medical Research Programs (CDMRP) grant to Aduro BioTech to complete the preclinical development of a new therapeutic cancer vaccine for prostate cancer. Aduro's cancer ...
Tags: Aduro, cancer vaccine platform, IND
Zogenix has commenced first IND clinical trial for Relday in patients with chronic, stable schizophrenia or schizoaffective disorder. Relday is based on a combination of its DosePro needle-free, subcutaneous drug delivery system with a ...
Tags: Clinical Trial, DosePro needle-free drug, pharmacokinetic
The US Federal Drug Administration (FDA) has received an application from Sobi for Kineret (anakinra) for the indication of neonatal-onset multisystem inflammatory disease (NOMID). The filing is made under an Orphan Drug Designation for ...
Skuldtech and AB Science have discovered a new set of blood markers predictive of a higher survival rate in pancreatic cancer patients. The companies are also planning to use the new markers for future companion test commercialization ...
Tags: skuldtech, AB science, blood markers, pancreatic cancer patients
Curis, a drug development company, has reported a net loss of $3.38m, or $0.04 per share, for the third quarter ended 30 September 2012 compared to a net loss of $4.21m, or $0.05 per share, for the third quarter ended 30 September 2011. ...
Tags: Net Loss, proprietary and licensed programs, clinical trial
The SFJ Pharmaceuticals Group (SFJ) has partnered with Pfizer to co-develop Dacomitinib as first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of epidermal ...
Tags: Cancer Drug, cell lung cancer, therapy
Ophthalmologic products provider, InSite Vision has started the patient enrollment for the first Phase 3 clinical trial of BromSite (ISV-303), which is used to reduce pain and inflammation post cataract surgery. The study will enroll ...
Tags: Insite Vision, BromSite Phase 3 Study, Ophthalmologic products
Azelon Pharmaceuticals has completed a phase 2a trial comparing nasal spray ZT-034 to Forteo administered by subcutaneous injection and placebo in women with low bone mass. Patients in the phase 2 study, which saw the enrollment of 130 ...